Egr2 targets identify a population of dysfunctional T cells in the tumor microenvironment with immune modulatory properties

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (76th percentile)
Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

patent: 3 patents

Readers on

mendeley: 4 Mendeley

Summary Patents

So far, Altmetric has seen 3 patents that reference this research output.

METHODS AND COMPOSITIONS RELATED TO T-CELL ACTIVITY

Application EP-4163387-A1

European Patent Office

METHODS AND COMPOSITIONS RELATED TO T-CELL ACTIVITY

Application EP-3404116-A1

European Patent Office

DYSFUNCTIONAL ANTIGEN-SPECIFIC CD8+ T CELLS IN THE TUMOR MICROENVIRONMENT

Application WO-2018186924-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.